Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified

Simply Wall StNov 23 07:31 ET

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 05:44 ET

Positive Outlook for Aurinia Pharmaceuticals Boosted by Favorable Lupus Nephritis Guidelines

TipRanksNov 21 01:17 ET

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 19 20:40 ET · Ratings

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 18 17:53 ET

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

ReutersNov 18 17:53 ET